SCHEMBL2323797

SCHEMBL2323797

O=[C]N1CCN(c2ccccc2Cl)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.55
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 1/20 0.51
PLA2G1B P04054 1/20 0.51
RAB9A P51151 1/20 0.51
ATG4B Q9Y4P1 1/20 0.51
AKR1C3 P42330 1/20 0.50
LMNA P02545 2/20 0.47
HTT P42858 1/20 0.47
HTR1A P08908 2/20 0.46
DRD2 P14416 3/20 0.46
DRD3 P35462 3/20 0.46
ADRA1B P35368 2/20 0.45
DRD4 P21917 2/20 0.45
HSD11B1 P28845 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
NOTUM Q6P988 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28396664 0.85 ADRB1 (0.71) ADRB1KDM4EALDH1A1PLA2G1BRAB9A
SCHEMBL2325937 0.81 SMN1; SMN2 (0.56) KDM4EALDH1A1LMNA
SCHEMBL2321072 0.79 DRD4 (0.49) ALDH1A1HTR1ADRD2DRD3ADRA1B
SCHEMBL3236477 0.77 DRD2 (0.65) ADRB1ALDH1A1AKR1C3LMNAHTR1A
SCHEMBL30407939 0.76 ADRB1 (0.65) ADRB1KDM4EALDH1A1PLA2G1BRAB9A
SCHEMBL1825806 0.76 ADRB1 (0.65) ADRB1KDM4EALDH1A1PLA2G1BRAB9A
SCHEMBL2323800 0.76 ADRB1 (0.55) ADRB1KDM4EALDH1A1PLA2G1BRAB9A
SCHEMBL2096393 0.75 ADRB1 (0.59) ADRB1KDM4EALDH1A1PLA2G1BRAB9A
SCHEMBL11216112 0.75 ADRB1 (0.59) ADRB1KDM4EALDH1A1PLA2G1BRAB9A
SCHEMBL424507 0.75 DRD2 (0.75) ADRB1KDM4EALDH1A1PLA2G1BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed